Hilde is a Director of the R&D Operations Innovation department at Janssen. She has more than 16 years of experience in pharmaceutical companies and clinical research organizations, where she held various leading positions in clinical operations, data management, safety management, professional affairs, quality management, strategic business improvement and clinical trial innovation. Prior to clinical research, Hilde worked as a research scientist for 6 years.
Hilde has a passion for complex or so called mission impossible projects and has a track record to transform them into success stories. At Janssen, she established the global expanded access and compassionate use programs, led the global harmonization of medical affairs operational processes, drove the Crucell R&D and QA transition, and many other initiatives. In her current role as Innovation Leader, she led several transformational projects, such as eConsent, eSource, eMeds/iSTEP (Integrated Smart Trial and Engagement Platform), to modernize Janssen’s clinical trials and improve the experience of patients and investigators. Next to her role in Janssen, Hilde is also the cross-pharma Transcelerate eConsent workstream leader were she leads the cross-industry adoption of eConsent implementation on a global level.
Hilde holds a degree in Engineering in Chemical and Agricultural Sciences, a Master in Environmental Sciences and a PhD in Medical Sciences, all from the Catholic University of Leuven in Belgium